02.12.2012 Views

Annual Report - Sonova Holding AG

Annual Report - Sonova Holding AG

Annual Report - Sonova Holding AG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Andy Rihs (born in 1942) has been Chairman of the Board of<br />

Directors of Phonak <strong>Holding</strong> <strong>AG</strong> since 1992. He is one of the founders of<br />

the Phonak Group, together with his partner, Beda Diethelm, and his<br />

brother Hans-Ueli Rihs.<br />

In 1966, Andy Rihs joined Beda Diethelm who came to Phonak a<br />

year earlier as technical manager. Andy Rihs began to build up the<br />

marketing and commercial aspect of the company. He first established a<br />

sales organization for Switzerland, then gradually built up a global distribution<br />

network. Andy Rihs led the Phonak Group as CEO until April<br />

2000, and as interim CEO, from April to September 2002. Under his leadership,<br />

the company grew continuously and succeeded in establishing an<br />

outstanding brand image for Phonak – known for products of the highest<br />

technological standard and reliability.<br />

Andy Rihs completed his education and business training primarily<br />

in Switzerland and France.<br />

Dr. h.c. Daniel Borel (born in 1950) has been Chairman of the<br />

Board of Logitech International Ltd. since 1988.<br />

He co-founded Logitech in 1981 and served as CEO from 1992 to<br />

1998. During this time, Daniel Borel was instrumental in growing<br />

Logitech around the world and establishing the company’s high-volume<br />

manufacturing capability in Asia. In 1988, he took the Logitech Group<br />

public on the SWX Swiss Exchange and in 1997 on Nasdaq.<br />

Daniel Borel holds an engineering degree from the Swiss Federal<br />

Institute of Technology Lausanne, Switzerland, and a master’s degree in<br />

Computer Science from Stanford University, California. He was awarded<br />

an honorary doctorate from Lausanne’s Federal Institute of Technology<br />

in 1992.<br />

Dr. Michael Jacobi (born in 1953) is CFO and member of the<br />

Executive Committee of Ciba Specialty Chemicals <strong>AG</strong> – a position he has<br />

held since 1997 and in which he is responsible for Treasury, M&A,<br />

Investor Relations, and Controlling.<br />

Michael Jacobi joined Ciba-Geigy’s Control & Management Services<br />

in 1978 when he held positions in finance, accounting, and planning<br />

in Brazil and the US. In 1987, he returned as Head of Management<br />

Accounting at the Finance Department in Basel, Switzerland, where he<br />

later became responsible for Ciba-Geigy’s overall corporate financial<br />

accounting and reporting.<br />

Michael Jacobi studied at the University of St. Gallen, Switzerland,<br />

at the Washington University in Seattle, and at the Harvard Business<br />

School in Boston. In St. Gallen, he earned a doctorate degree with a thesis<br />

on the International Accounting Standards.<br />

William D. Dearstyne (born in 1940) retired in April 2003 from his<br />

position as Company Group Chairman and member of the Medical<br />

Devices and Diagnostics Group Operating Committee of Johnson &<br />

Johnson.<br />

During the 34 years of his career managing diversified healthcare<br />

companies, he gained valuable business experience in Asia, Central and<br />

Eastern Europe as well as Latin America. He served in many different<br />

functions during his 26 years at Johnson & Johnson. Within this period,<br />

he also led two major acquisitions for the company – Cordis and DePuy<br />

– both of which today occupy leadership positions in interventional<br />

cardiology and orthopedics respectively.<br />

William D. Dearstyne studied at Bucknell University in Lewisburg,<br />

Pennsylvania, and at Syracuse University in New York where he earned<br />

an MBA in International Business.<br />

Heliane Canepa (born in 1948) has been President and CEO of<br />

Nobel Biocare AB, Sweden, a company primarily engaged in dental<br />

implants, since 2001. Since 2002, she has also been CEO of the newly<br />

established group parent company, Nobel Biocare <strong>Holding</strong> <strong>AG</strong>.<br />

Before joining Nobel Biocare, Heliane Canepa acted as CEO of the<br />

medical technology company Schneider Worldwide. In 1984, Schneider<br />

was sold to Pfizer Inc., which resold the entity to Boston Scientific in<br />

1998. Because Boston Scientific already had a European production site<br />

in Ireland, the location in Bülach, Switzerland, was closed. Heliane<br />

Canepa earned special merit for her work in assisting employees to find<br />

new employment opportunities. She was voted Entrepreneur of the year<br />

in Switzerland in 1995 and 1999.<br />

Heliane Canepa completed business school in Dornbirn, Austria,<br />

West London College in London, Sorbonne University in Paris, and the<br />

Foreign Executive Development Program at Princeton University, New<br />

Jersey.<br />

Robert F. Spoerry (born in 1955) is Chairman, President and CEO<br />

of Mettler-Toledo International Inc., a leading global manufacturer of<br />

precision instruments for use in laboratory, manufacturing and food<br />

retailing applications, quoted on the New York Stock Exchange (NYSE)<br />

since 1997.<br />

Robert F. Spoerry joined Mettler-Toledo in 1983, served as Head of<br />

the Industrial and Retail Division in Europe from 1987 until 1993, and<br />

was in charge of the lead in the acquisition and integration of Toledo<br />

Scale Corporation (USA). In 1989, he was appointed to the company’s<br />

Executive Board, was nominated CEO in 1993 and assigned Chairman in<br />

1998.<br />

Robert F. Spoerry graduated in mechanical engineering at the Federal<br />

Institute of Technology in Zurich, Switzerland, and received an MBA from<br />

the University of Chicago.<br />

Corporate Governance<br />

25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!